三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
BL-B01D1在TNBC、HR+/HER2-以及HER2+乳腺癌等适应症均展现出优异的客观缓解率
BL-B01D1在TNBC、HR+/HER2-以及HER2+乳腺癌等适应症均展现出优异的客观缓解率
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:486KB
图片尺寸:2346*1319
同报告图片
/
4
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
所属报告:
医药健康行业深度研究:从第一三共ADC药物商业成功看国内ADC投资映射-250308(20页).pdf
打包全文图表
相关数据
2020-2024年CNS临床试验启动数量(按适应症划分)
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
收藏
行业数据
2026-07-14
原图定位
查看详情
三大眼底类适应症全球患者总量超1亿
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
收藏
行业数据
2026-07-03
原图定位
查看详情
中国自免类靶向药主要适应症竞争格局
收藏
竞争格局
2026-06-15
原图定位
查看详情
海曲泊帕销售预测(仅包含CTIT适应症)
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
收藏
行业数据
2026-05-28
原图定位
查看详情
海曲泊帕在研适应症(截至2026年2月)
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
收藏
行业数据
2026-05-28
原图定位
查看详情
瑞康曲妥珠单抗与德曲妥珠单抗2LNSCLC适应症和数据对比(非头对头)
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
收藏
行业数据
2026-05-28
原图定位
查看详情
瑞康曲妥珠单抗销售预测(仅限肺癌适应症)
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
收藏
行业数据
2026-05-28
原图定位
查看详情
CDK4/6i耐药HR+乳腺癌III期阶段以后在研品种(最高研发阶段开始日期在2023年及以后)
PHRhYmxlIGJvcmRlcj0iMSIgY2VsbHNwYWNpbmc9IjAiIGNlbGxwYWRkaW5nPSI1Ij4KICAgIDx0aGVhZD4KICAgICAgICA8dHIgc3R5bGU9ImJhY2tncm91bmQtY29sb3I6ICNmZjAwMDA7IGNvbG9yOiB3aGl0ZTsiPgogICAgICAgICAgICA8dGg+6I2v5ZOB5ZCN56ewPC90aD4KICAgICAgICAgICAgPHRoPueglOWPkeacuuaehDwvdGg+CiAgICAgICAgICAgIDx0aD7kvZznlKjmnLrliLY8L3RoPgogICAgICAgICAgICA8dGg+6YCC5bqU55eH5YWo55CD5pyA6auY56CU5Y+R6Zi25q615byA5aeL5pel5pyfPC90aD4KICAgICAgICAgICAgPHRoPumAguW6lOeXh+WFqOeQg+acgOmrmOeglOWPkemYtuautTwvdGg+CiAgICAgICAgPC90cj4KICAgIDwvdGhlYWQ+CiAgICA8dGJvZHk+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+QXJ2ZWdlc3RyYW50PC90ZD4KICAgICAgICAgICAgPHRkPlBmaXplcjtBcnZpbmFzPC90ZD4KICAgICAgICAgICAgPHRkPkVSIFBST1RBQzwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDI1LTA2LTA2PC90ZD4KICAgICAgICAgICAgPHRkPueUs+ivt+S4iuW4gjwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD7lkInovr7liKnloZ48L3RkPgogICAgICAgICAgICA8dGQ+V3lldGg7IENlbGN1aXR5PC90ZD4KICAgICAgICAgICAgPHRkPm1UT1LmipHliLbliYI7QWt05oqR5Yi25YmCO1BJM0vmipHliLbliYI8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNS0wOC0yNzwvdGQ+CiAgICAgICAgICAgIDx0ZD7nlLPor7fkuIrluII8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+5ZCJ6Zu35Y+4576kPC90ZD4KICAgICAgICAgICAgPHRkPkdlbmVudGVjaCAoUm9jaGUpPC90ZD4KICAgICAgICAgICAgPHRkPumAieaLqeaAp+mbjOa/gOe0oOWPl+S9k+mZjeino+WJgjwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDI2LTAxLTI5PC90ZD4KICAgICAgICAgICAgPHRkPueUs+ivt+S4iuW4gjwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD50cmFzdHV6dW1hYiBwYW1pcnRlY2FuPC90ZD4KICAgICAgICAgICAgPHRkPuS4ieeUn+WItuiNrztCaW9OVGVjaDvmmKDmgannlJ/niak8L3RkPgogICAgICAgICAgICA8dGQ+YW50aS1IRVIy5oqX5L2T5YG26IGU6I2v54mpPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjMtMDgtMzA8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPnBhbGF6ZXN0cmFudDwvdGQ+CiAgICAgICAgICAgIDx0ZD5PbGVtYSBQaGFybWFjZXV0aWNhbHM8L3RkPgogICAgICAgICAgICA8dGQ+6YCJ5oup5oCn6ZuM5r+A57Sg5Y+X5L2T6ZmN6Kej5YmCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjMtMDgtMzA8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPuS8puW6t+S+nemahuWmpeWNleaKlzwvdGQ+CiAgICAgICAgICAgIDx0ZD5CcmlzdG9sLU15ZXJzIFNxdWliYjvnmb7liKnlpKnmgZI8L3RkPgogICAgICAgICAgICA8dGQ+RUdGUsOXSEVSM+aKl+S9k+WBtuiBlOiNr+eJqTwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDI0LTA0LTAzPC90ZD4KICAgICAgICAgICAgPHRkPklJSeacn+S4tOW6ijwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD5TSU0wMjcwPC90ZD4KICAgICAgICAgICAgPHRkPuWFiOWjsOiNr+S4mjwvdGQ+CiAgICAgICAgICAgIDx0ZD7pgInmi6nmgKfpm4zmv4DntKDlj5fkvZPpmY3op6PliYI8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNC0xMS0wNDwvdGQ+CiAgICAgICAgICAgIDx0ZD5JSUnmnJ/kuLTluoo8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+em92ZWdhbGlzaWI8L3RkPgogICAgICAgICAgICA8dGQ+UmVsYXkgVGhlcmFwZXV0aWNzO0RFU1JFUzwvdGQ+CiAgICAgICAgICAgIDx0ZD5QSTNLzrEgSDEwNDdY5oqR5Yi25YmCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMDUtMjE8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPuW+t+W4leabsuWmpeWwpOWNleaKlzwvdGQ+CiAgICAgICAgICAgIDx0ZD5NZXJjayAmIENvLjtEYWlpY2hpIFNhbmt5bzwvdGQ+CiAgICAgICAgICAgIDx0ZD5hbnRpLUhFUjPmipfkvZPlgbbogZToja/niak8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNS0wNy0xMTwvdGQ+CiAgICAgICAgICAgIDx0ZD5JSUnmnJ/kuLTluoo8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+cHJpZmV0cmFzdGF0PC90ZD4KICAgICAgICAgICAgPHRkPlBmaXplcjtDYW50aGVyYSBEaXNjb3Zlcnk8L3RkPgogICAgICAgICAgICA8dGQ+S0FUNkHmipHliLbliYI7S0FUNkLmipHliLbliYI8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNS0wNy0xNDwvdGQ+CiAgICAgICAgICAgIDx0ZD5JSUnmnJ/kuLTluoo8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+WUwyMDI8L3RkPgogICAgICAgICAgICA8dGQ+QmlvTlRlY2g75a6c6IGU55Sf54mpPC90ZD4KICAgICAgICAgICAgPHRkPmFudGktSEVSM+aKl+S9k+WBtuiBlOiNr+eJqTwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDI2LTAyLTI4PC90ZD4KICAgICAgICAgICAgPHRkPklJSeacn+S4tOW6ijwvdGQ+CiAgICAgICAgPC90cj4KICAgIDwvdGJvZHk+CjwvdGFibGU+CgrotYTmlpnmnaXmupDvvJrljLvoja/prZTmlrnvvIzkuK3ms7Dor4HliLjnoJTnqbbmiYA=
收藏
行业数据
2026-05-11
原图定位
查看详情
表10、国内“肤质改善”适应症,合规械三水光盘点
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
收藏
行业数据
2026-05-11
原图定位
查看详情
2018-2032E全球乳腺癌药物市场规模
fCDlubTku70gICB8IOW4guWcuuinhOaooe+8iOS6v+e+juWFg++8iSB8CnwtLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tfAp8IDIwMTggICB8IDI1MCAgICAgICAgICAgICAgIHwKfCAyMDE5ICAgfCAzOTAgICAgICAgICAgICAgICB8CnwgMjAyMCAgIHwgNDUwICAgICAgICAgICAgICAgfAp8IDIwMjEgICB8IDQ4MCAgICAgICAgICAgICAgIHwKfCAyMDIyICAgfCA0OTAgICAgICAgICAgICAgICB8CnwgMjAyMyAgIHwgNTMwICAgICAgICAgICAgICAgfAp8IDIwMjQgICB8IDU3MCAgICAgICAgICAgICAgIHwKfCAyMDI1RSAgfCA2MjAgICAgICAgICAgICAgICB8CnwgMjAyNkUgIHwgNjcwICAgICAgICAgICAgICAgfAp8IDIwMjdFICB8IDcyMCAgICAgICAgICAgICAgIHwKfCAyMDI4RSAgfCA3NjAgICAgICAgICAgICAgICB8CnwgMjAyOUUgIHwgODEwICAgICAgICAgICAgICAgfAp8IDIwMzBFICB8IDg0MCAgICAgICAgICAgICAgIHwKfCAyMDMxRSAgfCA4NzAgICAgICAgICAgICAgICB8CnwgMjAzMkUgIHwgODkwICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45oub6IKh5Lmm77yM5Lic5YyX6K+B5Yi4
收藏
市场规模
2026-05-09
原图定位
查看详情
全球肝癌药物适应症TOP10
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
收藏
行业数据
2026-04-30
原图定位
查看详情
中国肝癌药物适应症TOP10
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
收藏
行业数据
2026-04-30
原图定位
查看详情
瑞康曲妥珠单抗与德曲妥珠单抗2LNSCLC适应症和数据对比(非头对头)
收藏
行业数据
2026-04-20
原图定位
查看详情
瑞康曲妥珠单抗在研适应症(截至2026年2月)
收藏
行业数据
2026-04-20
原图定位
查看详情
全球范围临床阶段ASI高血压适应症在研情况(截至2026年3月25日)
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
收藏
行业数据
2026-04-01
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
乳腺癌方面,百利天恒全资子公司 SystImmune 在 2024 年 12 月第 47 届圣安东尼奥乳腺癌研讨会展示 BL-B01D1 的最新数据:截止到 2024 年 9 月 30 日,研究共入组 162 例患者。在 TNBC 队列中,观察到 BL-B01D1 治疗的 ORR高达 34.1%,其中在既往仅接受过一/二线化疗的 TNBC 患者中,ORR 达 50%,整体 PFS 接近 7 个月。对于 HR+/HER2-的患者,ORR 是 37.7%,PFS 为 7.0 个月,而在仅接受过一/二线化疗的患者中,ORR 提升至 45.7%,PFS 为 8.3 个月。在 HER2+的患者中,共纳入 40 例可评估患者,ORR 为 47.5%,PFS达到7 个月。
行业数据
原图定位
当前图表所属:
医药健康行业深度研究:从第一三共ADC药物商业成功看国内ADC投资映射-250308(20页).pdf
2025年 ADC药物行业报告:德曲妥珠单抗年销38亿美元,国产HER2 ADC对标趋势|国金证券
科伦博泰芦康沙妥珠单抗适应症布局广泛
FDA预计在2025年中对Datopotamabderuxtecan的肺癌适应症NDA做出决定
Enhertu和Datroway已经对不同亚型乳腺癌适应症形成了广泛的临床试验覆盖
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》